Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Nov 2;5(4):2978-86.
doi: 10.3390/biom5042978.

Update on Alcoholic Hepatitis

Affiliations
Review

Update on Alcoholic Hepatitis

Natalie J Torok. Biomolecules. .

Abstract

Alcoholic liver disease is one of the most prevalent liver diseases worldwide, and a major cause of morbidity and mortality. Alcoholic hepatitis is a severe form of liver injury in patients with alcohol abuse, can present as an acute on chronic liver failure associated with a rapid decline in liver synthetic function, and consequent increase in mortality. Despite therapy, about 30%-50% of patients with severe alcoholic hepatitis eventually die. The pathogenic pathways that lead to the development of alcoholic hepatitis are complex and involve oxidative stress, gut dysbiosis, and dysregulation of the innate and adaptive immune system with injury to the parenchymal cells and activation of hepatic stellate cells. As accepted treatment approaches are currently limited, a better understanding of the pathophysiology would be required to generate new approaches that improve outcomes. This review focuses on recent advances in the diagnosis, pathogenesis of alcoholic hepatitis and novel treatment strategies.

Keywords: IL22; TNFα; alcoholic liver injury; oxidative stress; steatohepatitis.

PubMed Disclaimer

References

    1. Zakhari S., Li T.K. Determinants of alcohol use and abuse: Impact of quantity and frequency patterns on liver disease. Hepatology. 2007;46:2032–2039. doi: 10.1002/hep.22010. - DOI - PubMed
    1. Rehm J., Mathers C., Popova S., Thavorncharoensap M., Teerawattananon Y., Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 2009;373:2223–2233. doi: 10.1016/S0140-6736(09)60746-7. - DOI - PubMed
    1. White A.M., Hingson R.W., Pan I.J., Yi H.Y. Hospitalizations for alcohol and drug overdoses in young adults ages 18–24 in the United States, 1999–2008: Results from the nationwide inpatient sample. J. Stud. Alcohol. Drugs. 2011;72:774–786. doi: 10.15288/jsad.2011.72.774. - DOI - PMC - PubMed
    1. Alexander J.F., Lischner M.W., Galambos J.T. Natural history of alcoholic hepatitis. II. The long-term prognosis. Am. J. Gastroenterol. 1971;56:515–525. - PubMed
    1. Poynard T., Mathurin P., Lai C.L., Guyader D., Poupon R., Tainturier M.H., Myers R.P., Muntenau M., Ratziu V., Manns M., et al. A comparison of fibrosis progression in chronic liver diseases. J. Hepatol. 2003;38:257–265. doi: 10.1016/S0168-8278(02)00413-0. - DOI - PubMed

Publication types

LinkOut - more resources